MORTALITY AMONG CRITICALLY ILL PATIENTS WITH COVID-19 WHO RECEIVED TOCILIZUMAB

被引：0
|
作者：
Kruer, Rachel [1 ]
Tran, Mya [2 ]
Pollander, Abby [2 ]
Fadel, William [3 ,4 ]
Desai, Armisha [2 ]
机构：
[1] Indiana Univ Hlth, Indianapolis, IN USA
[2] Indiana Univ Hlth, Methodist Hosp, Indianapolis, IN USA
[3] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Biostat & Hlth Data Sci, Indianapolis, IN 46204 USA
[4] Sch Med, Indianapolis, IN USA
来源：
CRITICAL CARE MEDICINE | 2022年 / 50卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
252
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [21] Predictive biomarkers of mortality in critically ill patients with COVID-19
    Sirvent, J. M.
    Baro, A.
    Morales, M.
    Sebastian, P.
    Saiz, X.
    [J]. MEDICINA INTENSIVA, 2022, 46 (02) : 94 - 96
  • [22] Factors associated with mortality in critically ill patients with COVID-19
    de Almeida, Rafaela dos Santos Charao
    Klafke, Andre
    Garbini, Andresa Fontoura
    Carazai, Daniela dos Reis
    dos Santos, Fernanda Costa
    Lutkmeier, Raquel
    Baldon, Veridiana
    [J]. REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO, 2022, 12 (04):
  • [23] Predictors of mortality in critically ill patients with COVID-19 and diabetes
    Lazaro, A. P. P.
    Zaranza, M. S.
    Meneses, G. C.
    Aragao, N. L.
    Freire, M. V. P.
    Guimaraes, A. R.
    Beliero, A. M.
    Dantas, M. M. P.
    Forte, L. C.
    Martins, A. M. C.
    Daher, E. F.
    Albuquerque, P. L. M. M.
    da Silva Junior, G. B.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2023, 56
  • [24] Impact of immunosuppression on mortality in critically ill COVID-19 patients
    Mirouse, Adrien
    Darmon, Michael
    Zafrani, Lara
    Lengline, Etienne
    Azoulay, Elie
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (03) : 394 - 395
  • [25] Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
    Jonmarker, Sandra
    Hollenberg, Jacob
    Dahlberg, Martin
    Stackelberg, Otto
    Litorell, Jacob
    Everhov, Asa H.
    Jarnbert-Pettersson, Hans
    Soderberg, Marten
    Grip, Jonathan
    Schandl, Anna
    Gunther, Mattias
    Cronhjort, Maria
    [J]. CRITICAL CARE, 2020, 24 (01)
  • [26] Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
    Sandra Jonmarker
    Jacob Hollenberg
    Martin Dahlberg
    Otto Stackelberg
    Jacob Litorell
    Åsa H. Everhov
    Hans Järnbert-Pettersson
    Mårten Söderberg
    Jonathan Grip
    Anna Schandl
    Mattias Günther
    Maria Cronhjort
    [J]. Critical Care, 24
  • [27] Clinical Risk Factors for Mortality Among Critically Ill Mexican Patients With COVID-19
    Hernandez-Cardenas, Carmen M.
    Alberto Choreno-Parra, Jose
    Torruco-Sotelo, Carlos
    Jurado, Felipe
    Serna-Secundino, Hector
    Aguilar, Cristina
    Garcia-Olazaran, Jose G.
    Hernandez-Garcia, Diana
    Choreno-Parra, Eduardo M.
    Zuniga, Joaquin
    Lugo-Goytia, Gustavo
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [28] Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 (vol 181, pg 41, 2021)
    Gupta, S.
    Wang, H.
    Hayek, S. S.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (04) : 570 - 570
  • [29] Efficacy of Tocilizumab in Critically Ill COVID-19 Patients Followed in the Intensive Care Unit
    Saruhan, Resit
    Uzundere, Osman
    [J]. TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI, 2024, 22 (03): : 197 - 206
  • [30] Clinical Outcomes among Hospitalized COVID-19 Patients Who Received Baricitinib or Tocilizumab in Addition to Standard of Care
    Walker, Cucnhat P.
    Hurlock, Natalie P.
    Deb, Subrata
    [J]. DISEASES, 2024, 12 (05)
12345